Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting

Malaria Journal

Meeting Report

关键词: Global;    Malaria;    WHO;    Policy development;    Sulphadoxine-pyrimethamine;    Pregnancy;    Prevention;    Primaquine;    Gametocytes;    Plasmodium falciparum;    Plasmodium vivax;    Diagnostic tests;    Drug resistance;    Surveillance;    Mosquito control;   

DOI  :  10.1186/1475-2875-11-424

 received in 2012-11-28, accepted in 2012-11-30,  发布年份 2012

来源: Springer

【 摘 要 】

The Malaria Policy Advisory Committee to the World Health Organization met in Geneva, Switzerland from 11 to 13 September, 2012. This article provides a summary of the discussions, conclusions and recommendations from that meeting.Meeting sessions included: updated policy recommendations on the use of sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of malaria in pregnancy, as well as the use of single dose primaquine as a Plasmodium falciparum gametocytocide; the need to develop a Global Technical Strategy for Malaria Control and Elimination 2016– 2025 and a global strategy for control of Plasmodium vivax; the Affordable Medicines Facility for malaria independent evaluation and promoting malaria case management in the private sector; updates from the Technical Expert Group on drug resistance and containment and the Evidence Review Group on malaria burden estimation; update on the RTS,S/AS01 malaria vaccine; progress on the policy setting process for malaria vector control; and the process for updating the WHO Guidelines for the Treatment of Malaria.Policy statements, position statements, and guidelines that arise from the MPAC meeting conclusions and recommendations will be formally issued and disseminated to World Health Organization Member States by the World Health Organization Global Malaria Programme.

【 授权许可】

Unknown   
© WHO Malaria Policy Advisory Committee and Secretariat; licensee BioMed Central Ltd. 2012. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.